Literature DB >> 3392212

Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).

H D Perez1, E Kelly, D Chenoweth, F Elfman.   

Abstract

The chemotactic activity of human C5a des Arg is enhanced significantly by an anionic polypeptide (cochemotaxin) in normal human serum and plasma. The cochemotaxin attaches to sialic acid residues within the oligosaccharide chain of native C5a des Arg to form a complex with potent chemotactic activity for human PMN. We investigated the nature of the cochemotaxin and found that vitamin D-binding protein is the putative cochemotaxin. Vitamin D-binding protein enhanced the chemotactic activity of native C5a des Arg, but had no effect on the chemotactic activity of either native C5a or FMLP. Sialic acid prevented both enhancement by vitamin D-binding protein of the chemotactic activity of native C5a des Arg and formation of C5a des Arg-vitamin D-binding protein complexes, detected by molecular sieve chromatography. Furthermore, vitamin D-binding protein and cochemotaxin exhibited identical molecular weights, isoelectric points, antigenic reactivity, and amino acid composition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3392212      PMCID: PMC303517          DOI: 10.1172/JCI113595

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  The chemokinetic effect of serum albumin.

Authors:  H U Keller; M W Hess; H Cottier
Journal:  Experientia       Date:  1977-10-15

3.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function.

Authors:  R O Webster; S R Hong; R B Johnston; P M Henson
Journal:  Immunopharmacology       Date:  1980-06

5.  Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity.

Authors:  C Gerard; D E Chenoweth; T E Hugli
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

6.  Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide ("cochemotaxin") in normal serum and plasma.

Authors:  H D Perez; I M Goldstein; R O Webster; P M Henson
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

7.  Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.

Authors:  H D Perez; D E Chenoweth; I M Goldstein
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

8.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

9.  Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.

Authors:  V A Bokisch; H J Müller-Eberhard
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  17 in total

1.  Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3.

Authors:  Anisha B Shah; Stephen J DiMartino; Glenda Trujillo; Richard R Kew
Journal:  Mol Immunol       Date:  2005-08-22       Impact factor: 4.407

2.  Upregulation of vitamin D binding protein (Gc-globulin) binding sites during neutrophil activation from a latent reservoir in azurophil granules.

Authors:  Stephen J DiMartino; Glenda Trujillo; Lauren A McVoy; Jianhua Zhang; Richard R Kew
Journal:  Mol Immunol       Date:  2006-11-20       Impact factor: 4.407

3.  1,25-Dihydroxycholecalciferol inhibits the cochemotactic activity of Gc (vitamin D binding protein).

Authors:  M Petrini; A Azzarà; G Carulli; B Grassi; F Ambrogi; R M Galbraith
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

4.  Cofactor regulation of C5a chemotactic activity in physiological fluids. Requirement for the vitamin D binding protein, thrombospondin-1 and its receptors.

Authors:  Glenda Trujillo; Jianhua Zhang; David M Habiel; Lingyin Ge; Mahalakshmi Ramadass; Berhane Ghebrehiwet; Richard R Kew
Journal:  Mol Immunol       Date:  2011-10-19       Impact factor: 4.407

5.  Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.

Authors:  Mingyang Song; Gauree Gupta Konijeti; Chen Yuan; Ashwin N Ananthakrishnan; Shuji Ogino; Charles S Fuchs; Edward L Giovannucci; Kimmie Ng; Andrew T Chan
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-31

6.  Gc globulin (vitamin D-binding protein) increases binding of low concentrations of C5a des Arg to human polymorphonuclear leukocytes: an explanation for its cochemotaxin activity.

Authors:  H D Perez
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

7.  Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types.

Authors:  A Braun; R Bichlmaier; H Cleve
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

8.  A monoclonal antibody against human vitamin-D-binding protein for the analysis of genetic variation in the group-specific component system (Gc).

Authors:  R Hoffmann; A Braun; H Cleve
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

Review 9.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  Molecular evaluation of an Alu repeat including a polymorphic variable poly(dA) (AluVpA) in the vitamin D binding protein (DBP) gene.

Authors:  A Braun; R Bichlmaier; B Müller; H Cleve
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.